Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health
Type

Research/project funding

Posted on

Date limite d´inscription

Reference Number

PAR-22-185

The purpose of this FOA is to provide a method for investigators to request gap filling preclinical services to academic and private institutions to assist with product development efforts and facilitate the advancement of promising therapeutics for HIV and HIV-associated co-infections (Hepatitis B, Hepatitis C and Tuberculosis).
Categories: Health.

More Information

Visit Website

Type

Research/project funding

Posted on

Date limite d´inscription

Reference Number

PAR-22-185

États-Unis